IA
EW icon

Integrity Alliance’s Edwards Lifesciences EW Stock Holding History

Integrity Alliance’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
3,168
+364
+13% +$30.5K 0.01% 681
2026
Q1 		$225K Buy
2,804
+41
+1% +$3.38K 0.01% 674
2025
Q4 		$236K Buy
+2,763
New +$227K 0.01% 680
2025
Q2 		– Sell
-3,168
Closed -$230K – 533
2025
Q1 		$230K Buy
+3,168
New +$227K 0.01% 553

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Integrity Alliance's EW Position: Q2 2026 in Review

Integrity Alliance increased its Edwards Lifesciences (EW) stake by 13% in Q2 2026, buying an estimated $30.5K and bringing the position to 3,168 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #681.

Integrity Alliance first reported a position in EW in Q1 2025 and has held it in 4 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Integrity Alliance held 3,168 shares of Edwards Lifesciences worth $287K as of Q2 2026.
  • Integrity Alliance bought 364 Edwards Lifesciences shares in Q2 2026, an estimated $30.5K.
  • Edwards Lifesciences made up 0.01% of Integrity Alliance's portfolio in Q2 2026, its #681 holding.
  • Integrity Alliance first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 4 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.